FleishmanHillard has appointed Emily Graham as its first chief diversity and inclusion officer. Before joining FleishmanHillard in 2017, Graham held senior positions at MWWPR and Burson-Marsteller. In her new role, she will work alongside a global DE&I taskforce to analyze recruitment, retention, compensation, training and development opportunities for colleagues. Graham will also continue to provide client counsel through her leadership of True Mosaic, a newly developed DE&I offering for clients. This offering will complement FH Perspectives, the agency’s internal engine for DE&I. Graham will report to CEO and president John Saunders and chief operating officer J.J. Carter. “Emily already touches many critical parts of our business; in this role, she’ll be 100 percent focused on helping us take action, enable meaningful change and measure progress,” said Saunders.
Clarity has named Elizabeth Minton vice president of global sales and marketing. Minton comes to Clarity from Independence Public Relations, where she served as vice president, marketing. Her previous positions include head of business development & corporate marketing at Blue Fountain Media and senior vice president, marketing and business development at 5W Public Relations. At Clarify, Minton will work closely with the agency’s leadership team and individual offices to elevate its brand, as well as identifying and expanding new business opportunities for the agency globally. Based out of Clarity’s New York office, Elizabeth will report to CEO Sami McCabe and will be responsible for global initiatives across the agency’s offices in New York, San Francisco, Los Angeles, and London.
Novavax, a late-stage biotechnology company, has brought on Silvia Taylor as senior vice president, investor relations and corporate affairs. Taylor comes to Novavax from Autolus Therapeutics, where she was vice president of global corporate affairs and communications, leading all financial, scientific and corporate communications. She was previously senior vice president of global investor relations and corporate affairs at Sucampo and has held executive marketing positions at MedImmune and Pfizer. At Novavax, Taylor will oversee the company’s investor relations, public relations and corporate communications activities.